Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,21507,774,1.10 [0.91-1.32],0.322319444697986
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21513,123,1.16 [0.74-1.81],0.5259108387248886
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22856,126,0.84 [0.50-1.40],0.4997475022786591
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17025,431,1.23 [0.97-1.56],0.0947452469554671
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22804,74,0.79 [0.40-1.58],0.5066875348263498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22193,69,1.24 [0.71-2.16],0.4471970136657233
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23675,73,0.77 [0.38-1.56],0.4725572180579451
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23694,49,0.83 [0.36-1.92],0.6698110346590609
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21716,40,1.50 [0.78-2.89],0.2240168914069912
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23255,93,1.18 [0.72-1.93],0.5145802064948395
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23221,59,1.18 [0.64-2.19],0.5933272022337212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23732,57,0.99 [0.48-2.01],0.9679160731428332
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23692,92,1.33 [0.84-2.10],0.2213052855584639
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23684,84,1.35 [0.84-2.17],0.2122865516332445
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Mycoses,23527,43,1.59 [0.89-2.83],0.1155390753977456
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22977,325,1.02 [0.76-1.36],0.9116612260077472
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22771,119,0.74 [0.43-1.29],0.2905079753515669
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22863,211,0.98 [0.68-1.42],0.9235883752511286
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",20578,27,1.59 [0.79-3.20],0.1922103317846356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20593,42,0.44 [0.15-1.24],0.1185129580702348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",20660,109,0.90 [0.53-1.52],0.6860485060979733
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",20665,114,nan [nan-nan],
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",11567,255,0.93 [0.66-1.31],0.6743506791780692
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9260,21,0.64 [0.16-2.58],0.5349419884955677
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20594,43,0.70 [0.27-1.80],0.4608578671838187
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21939,699,1.00 [0.81-1.22],0.9907985095347932
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22847,181,1.10 [0.76-1.61],0.6063447603948442
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23379,72,1.30 [0.78-2.18],0.3172212406078927
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23799,69,1.00 [0.53-1.88],0.9983368972015848
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Rectum,23602,40,1.23 [0.59-2.57],0.5870516135467957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23798,33,1.03 [0.43-2.51],0.9403131258511744
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm: Stomach,23836,27,0.81 [0.27-2.45],0.7060561475115981
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm,23573,259,1.03 [0.75-1.43],0.8497277264793538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23778,104,1.02 [0.61-1.70],0.9332106247862844
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23782,79,1.12 [0.64-1.94],0.6952784897231739
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23751,41,1.08 [0.50-2.34],0.8431053777498588
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,"Haemangioma, any site",23753,41,1.08 [0.50-2.34],0.8429255864018503
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi,23654,202,0.88 [0.60-1.31],0.5326862882743646
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23801,91,0.88 [0.49-1.57],0.6669648285497638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Other benign neoplasms of skin,23716,159,0.84 [0.53-1.32],0.4428185692633413
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Benign neoplasm of breast,13147,81,0.96 [0.53-1.73],0.8877993033246773
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter II Neoplasms,Leiomyoma of uterus,12857,594,1.06 [0.86-1.31],0.5767167550807006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23000,166,0.82 [0.52-1.29],0.3883214891641496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22884,300,1.18 [0.89-1.55],0.2504076115930977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22884,300,1.18 [0.89-1.55],0.2504076115930977
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),21831,304,1.03 [0.76-1.39],0.8658643867215059
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23410,69,0.60 [0.28-1.29],0.1906577718531842
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23618,84,1.29 [0.79-2.13],0.3114561805212816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,20878,606,1.06 [0.86-1.32],0.5670807383913454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22744,372,0.91 [0.69-1.21],0.5257788765884187
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,22264,86,1.00 [0.57-1.76],0.9979796947435476
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23171,50,0.99 [0.46-2.14],0.9786439926279602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22253,75,1.15 [0.66-2.00],0.6202468106868422
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,22456,278,1.18 [0.87-1.60],0.2885207606545167
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,22449,271,1.18 [0.87-1.61],0.2794038421972049
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22164,152,1.24 [0.80-1.92],0.334625107728563
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22168,150,1.24 [0.80-1.93],0.336337921683157
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,20742,470,1.10 [0.86-1.39],0.447779644436712
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20337,65,1.47 [0.88-2.45],0.1382744263333287
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,20706,434,1.07 [0.83-1.38],0.594049096731815
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20311,39,1.78 [1.05-3.01],0.0330956363940541
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",20331,59,1.05 [0.54-2.05],0.891848699414239
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Any mental disorder,20668,661,1.01 [0.81-1.25],0.9552472275931528
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20268,261,0.91 [0.63-1.31],0.6173196207962266
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23473,198,0.87 [0.58-1.32],0.5199516835873255
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23525,144,0.85 [0.52-1.37],0.5003139948948101
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,22130,68,1.04 [0.55-1.98],0.9006225961006402
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23740,68,1.03 [0.54-1.96],0.9376283416278944
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",20075,68,1.05 [0.55-2.01],0.8810098155951682
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Alcohol dependence,22146,84,0.93 [0.50-1.72],0.8087081221376753
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Smoking dependency,22096,61,1.23 [0.63-2.42],0.542326141467907
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20077,70,0.96 [0.49-1.86],0.8969675150534562
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20332,325,1.12 [0.84-1.49],0.4436227241205378
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression,22344,282,1.06 [0.78-1.45],0.7189537005191629
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,20209,246,1.04 [0.74-1.46],0.833988832143579
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20132,125,0.79 [0.46-1.35],0.3842958572487106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,22551,57,0.65 [0.28-1.51],0.3183807157770042
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Neurological diseases,21213,1266,0.98 [0.84-1.15],0.8321316133149343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19755,154,1.08 [0.72-1.62],0.7155353000356164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23652,124,0.94 [0.58-1.53],0.8091064643731063
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22697,426,1.05 [0.81-1.35],0.7108870017143027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Epilepsy,22419,148,0.79 [0.49-1.29],0.3535983787973679
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Migraine,22358,87,1.19 [0.72-1.98],0.493011897784655
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23517,77,1.24 [0.73-2.08],0.4282627049567574
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23414,35,1.62 [0.87-3.01],0.1281994947042555
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other sleep disorders,22419,148,1.02 [0.65-1.60],0.9202105229586964
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Sleep apnoea,23306,113,1.21 [0.76-1.93],0.4145104230491437
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22859,530,0.92 [0.72-1.17],0.4869242047528634
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22450,121,1.14 [0.73-1.76],0.5689809104395291
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22614,285,0.82 [0.58-1.15],0.2511660304529084
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23657,76,0.83 [0.43-1.61],0.5819430166096247
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Hemiplegia,23631,50,0.90 [0.41-1.98],0.7914824815864792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Other neurological diseases,23459,108,1.13 [0.71-1.82],0.6037502493646192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23430,274,0.83 [0.59-1.18],0.3070178550622621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23303,147,0.81 [0.50-1.31],0.3943437684337459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23235,79,0.87 [0.46-1.64],0.6733594778913633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23244,88,0.76 [0.40-1.43],0.3932672473642371
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23199,43,0.70 [0.27-1.77],0.4470226859712501
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22351,53,2.26 [1.59-3.22],5.181280912819556e-06
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22457,159,1.39 [1.00-1.95],0.0521432079270816
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23304,106,1.23 [0.78-1.92],0.3738394004155649
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23621,17,1.86 [0.86-4.05],0.1175233544372347
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1510,17,2.07 [0.95-4.53],0.0681202171502648
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",22128,17,1.85 [0.84-4.04],0.1242007306714873
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23513,41,1.15 [0.55-2.44],0.7093680947826662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23494,22,0.35 [0.08-1.61],0.1779951531960646
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23425,82,1.10 [0.64-1.89],0.7395765334898324
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23473,89,0.86 [0.47-1.57],0.6314992881306792
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23722,110,1.22 [0.78-1.91],0.3737552748707861
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,23384,83,1.30 [0.80-2.11],0.2965326086464278
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,18619,1701,1.09 [0.95-1.25],0.204549848237137
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23560,36,1.20 [0.55-2.61],0.6515247817362584
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",19520,1142,1.00 [0.85-1.19],0.9652534309396312
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertension,19535,1157,1.02 [0.87-1.21],0.788614448488212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18407,29,1.76 [0.93-3.34],0.0849881578233072
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22549,492,1.27 [1.03-1.58],0.0273001255130811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Angina pectoris,22355,298,1.53 [1.21-1.94],0.0004394574234449
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23217,117,1.53 [1.06-2.22],0.0231150744412423
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23321,221,1.17 [0.84-1.64],0.3431611712845424
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23739,51,1.05 [0.50-2.18],0.8997459009424029
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22195,138,0.80 [0.48-1.33],0.3826708533210385
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22417,368,1.12 [0.86-1.47],0.3921154966337145
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23392,75,1.15 [0.66-2.00],0.6276732969748152
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23395,158,1.21 [0.84-1.76],0.305198137384554
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23376,59,1.32 [0.75-2.32],0.3362085389842061
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23377,60,1.30 [0.74-2.30],0.3656242669156117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18434,56,1.35 [0.76-2.40],0.3069198013382647
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21582,40,1.64 [0.89-3.02],0.1121544777467355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Conduction disorders,21608,66,1.76 [1.15-2.70],0.0098868785561923
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16219,80,0.98 [0.54-1.79],0.951031239977119
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16311,172,1.33 [0.95-1.85],0.0950909081075553
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,21578,36,1.43 [0.70-2.90],0.323997430282786
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21593,51,1.45 [0.81-2.58],0.20888073110125
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23402,109,1.60 [1.10-2.32],0.013204412491728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23370,97,0.70 [0.37-1.31],0.2685206967038602
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23400,73,0.64 [0.31-1.36],0.2470352275937134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23442,63,0.72 [0.33-1.55],0.3986922882574654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23186,44,1.55 [0.86-2.83],0.148029642473784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23217,75,1.06 [0.58-1.93],0.8493701240233533
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22786,104,1.27 [0.81-1.98],0.300410355376174
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22769,87,1.15 [0.68-1.95],0.6009264892527146
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23697,84,1.07 [0.62-1.87],0.8012596407371585
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Varicose veins,23059,377,1.05 [0.80-1.36],0.7443430892544722
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,Hypotension,23208,42,1.24 [0.60-2.54],0.5589721251813502
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,20173,1686,0.98 [0.85-1.12],0.7439016089893282
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23634,115,1.24 [0.80-1.91],0.3430506898999127
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,22813,160,1.17 [0.80-1.72],0.4135997085036498
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",22788,135,1.20 [0.80-1.81],0.3705255329067048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23296,194,0.75 [0.48-1.16],0.1988138294721285
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23295,193,0.74 [0.48-1.16],0.1887658358571431
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23069,568,0.84 [0.66-1.07],0.1623155003213643
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,22588,87,0.60 [0.30-1.19],0.1458287934131343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Nasal polyp,22595,94,0.82 [0.45-1.49],0.5225778603482403
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22862,361,0.81 [0.60-1.11],0.1849382340763413
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,22691,190,0.77 [0.50-1.19],0.2382670781819857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13685,41,1.37 [0.70-2.66],0.3566126564184928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21813,767,1.08 [0.89-1.31],0.4252606360513937
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Early onset COPD,23229,92,1.17 [0.67-2.05],0.5770743223787205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23229,92,1.17 [0.67-2.05],0.5770743223787205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",23229,92,1.17 [0.67-2.05],0.5770743223787205
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22317,692,1.09 [0.90-1.33],0.3826548732544819
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Asthma,18204,692,1.08 [0.89-1.32],0.4494521373642662
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18075,692,1.08 [0.89-1.32],0.4375201696747239
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18189,677,1.08 [0.88-1.32],0.4671967598152885
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23668,53,1.52 [0.89-2.60],0.1254672995251859
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,22669,41,1.76 [1.01-3.06],0.045198379989086
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23724,41,1.72 [1.00-2.97],0.0515228012769504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22663,35,1.78 [0.97-3.25],0.0606046032998484
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Pleural effusion,22672,67,0.91 [0.46-1.80],0.7843317084845486
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,22761,156,1.26 [0.87-1.83],0.223634192323455
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23101,71,1.43 [0.88-2.33],0.1465218549532229
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,16926,4434,1.01 [0.92-1.11],0.8662166919140201
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23315,419,0.91 [0.69-1.20],0.50654813137228
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23771,119,0.66 [0.37-1.17],0.1543559616347113
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Impacted teeth,23776,110,0.58 [0.31-1.08],0.0856690138874957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Dental caries,22997,101,0.91 [0.52-1.59],0.734934286420163
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22988,92,1.04 [0.61-1.79],0.8777839583863787
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23758,133,0.65 [0.38-1.13],0.1249659677988707
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22971,75,1.09 [0.62-1.94],0.7646421236655258
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22765,51,0.77 [0.34-1.79],0.5471587211807507
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23728,38,0.84 [0.33-2.15],0.7162703742726594
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19167,176,1.10 [0.74-1.64],0.6317680786311645
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",20515,1524,0.98 [0.85-1.13],0.8128943211503658
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophagitis,19224,233,0.87 [0.60-1.28],0.4870138316549728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19483,492,0.99 [0.77-1.26],0.9168140879049366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19048,57,1.05 [0.52-2.14],0.8885123694694969
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19112,121,0.96 [0.58-1.58],0.8645430859505971
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19015,24,1.04 [0.36-3.04],0.9394152176051525
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Gastric ulcer,19077,86,0.89 [0.48-1.66],0.7243313200845952
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,19082,91,1.37 [0.84-2.21],0.2036310875859961
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23743,64,1.34 [0.77-2.33],0.2960703644660249
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Chronic gastritis,19086,95,0.69 [0.36-1.33],0.2695529404601625
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19544,553,1.07 [0.86-1.34],0.5426144293990762
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of appendix,23673,138,0.66 [0.39-1.13],0.132945866577227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,19334,343,1.01 [0.76-1.34],0.9589375821098688
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19085,94,0.91 [0.51-1.62],0.7584613112987599
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23665,171,1.08 [0.73-1.59],0.7030573805047786
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute appendicitis,23643,108,0.67 [0.37-1.22],0.193190205239607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Hernia,21501,1018,0.97 [0.82-1.16],0.755703425552653
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Inguinal hernia,20820,337,0.89 [0.65-1.22],0.4738049531778636
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Umbilical hernia,20583,100,1.09 [0.64-1.84],0.7492222499662338
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ventral hernia,20558,75,1.02 [0.54-1.91],0.9521445767222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,21016,533,1.02 [0.80-1.29],0.8854008113691189
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23084,645,1.14 [0.94-1.39],0.1781881424688656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,19614,1437,1.11 [0.97-1.28],0.1288215389988007
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23548,61,1.18 [0.64-2.18],0.5948059006949473
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23765,88,1.17 [0.70-1.96],0.5405275329511939
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn disease,22527,88,1.17 [0.70-1.96],0.5395841579343108
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22507,68,1.33 [0.78-2.26],0.2967955909136788
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23715,114,0.99 [0.60-1.62],0.9686834861756396
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,22553,114,0.99 [0.60-1.63],0.9740562846172496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22536,97,0.95 [0.55-1.65],0.8686642724852508
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22958,519,1.17 [0.95-1.45],0.1412108350063501
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22954,515,1.18 [0.96-1.46],0.123390591895716
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18235,58,0.75 [0.34-1.65],0.4704408555941164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal stricture,23541,58,0.73 [0.33-1.62],0.4416763680103249
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18219,42,0.61 [0.23-1.65],0.3310291742697547
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,18438,261,1.11 [0.82-1.52],0.4906859042072335
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18322,145,1.09 [0.72-1.65],0.6826618203030883
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18388,211,1.33 [0.98-1.80],0.0649753896621351
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Constipation,22840,186,1.31 [0.95-1.81],0.0997778354670115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23473,71,1.29 [0.77-2.18],0.3379380756832771
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18336,159,1.11 [0.75-1.65],0.5931115456533259
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18259,82,1.13 [0.65-1.95],0.6612511094712854
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18864,687,1.04 [0.85-1.27],0.7290950060483048
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,18334,157,1.23 [0.85-1.78],0.2675499088652013
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23463,61,1.26 [0.71-2.22],0.4275766188363105
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of liver,23201,105,1.08 [0.65-1.78],0.7651432108843212
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of liver,23156,60,0.78 [0.36-1.69],0.5278594772678193
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22748,447,1.00 [0.77-1.29],0.986400268107159
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholelithiasis,22658,357,0.92 [0.68-1.23],0.5759043097443053
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Cholecystitis,22362,61,1.54 [0.96-2.48],0.0749673056043763
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22337,36,0.84 [0.32-2.18],0.7137742620639029
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,22351,50,0.68 [0.28-1.65],0.3924666127298488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23679,50,0.67 [0.28-1.63],0.3779978761812282
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22747,245,1.34 [1.01-1.78],0.0449391867398263
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22560,58,1.43 [0.83-2.44],0.197639686642663
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Coeliac disease,22549,47,1.27 [0.65-2.46],0.4866835605705676
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22538,36,1.45 [0.76-2.78],0.260440222917877
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22658,156,1.33 [0.93-1.90],0.1196575267048327
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XI Diseases of the digestive system,GI-bleeding,22653,151,1.33 [0.92-1.91],0.1236881384554907
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,21628,1280,1.08 [0.93-1.25],0.3035041833415036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23503,87,0.52 [0.25-1.06],0.0722447195808675
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23475,404,1.13 [0.88-1.45],0.3272027895582348
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22881,453,1.12 [0.88-1.41],0.3612242663541518
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23156,354,1.16 [0.89-1.50],0.2753724520249164
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22897,95,1.23 [0.75-2.01],0.4067488524696492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23002,200,1.08 [0.76-1.55],0.6574102994921394
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23611,72,1.66 [1.08-2.54],0.0214653952292237
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23598,59,1.73 [1.10-2.73],0.0185124197880658
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23581,42,1.44 [0.75-2.78],0.2767475557945418
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23695,27,0.57 [0.17-1.97],0.3742494419958427
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23692,24,0.65 [0.18-2.33],0.5127052439421552
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23127,56,0.75 [0.34-1.68],0.4848066688460504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23379,308,1.08 [0.81-1.45],0.5940390997974576
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22487,59,1.04 [0.54-2.01],0.906439535319292
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22509,81,0.75 [0.38-1.46],0.3909486948071656
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22498,70,0.54 [0.24-1.19],0.1263295439093192
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22605,177,1.15 [0.80-1.66],0.4495672918416608
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22583,155,1.23 [0.84-1.78],0.2844743800310135
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,18452,3025,1.01 [0.90-1.12],0.9134222855361708
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19820,1610,0.97 [0.85-1.12],0.7092635333442374
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21717,944,1.14 [0.97-1.34],0.1163006903236958
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18322,112,0.99 [0.60-1.65],0.9828959977650232
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18514,304,1.13 [0.85-1.51],0.3934343175983492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23543,107,0.99 [0.59-1.65],0.9565409504960984
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23555,95,1.02 [0.59-1.75],0.9407347708407948
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,18782,572,1.02 [0.81-1.28],0.8719791915673083
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20979,572,1.03 [0.83-1.29],0.7640746754815746
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18249,39,1.02 [0.44-2.38],0.9568869155285288
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23503,38,0.98 [0.41-2.35],0.9690819397290654
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18341,131,1.21 [0.80-1.83],0.3765128753349633
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18231,21,0.26 [0.05-1.25],0.0934346907177343
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18318,108,1.09 [0.68-1.76],0.7114871273722809
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23730,55,0.80 [0.36-1.75],0.5727647271808501
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18499,289,0.99 [0.72-1.35],0.9336343517770622
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18401,191,1.08 [0.74-1.58],0.6758683687095355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19270,1060,0.94 [0.79-1.11],0.4563878053995547
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18245,35,0.57 [0.19-1.70],0.3136513052385776
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18362,152,0.75 [0.46-1.22],0.2409873232166831
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18235,25,0.61 [0.17-2.17],0.4465329988510366
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18235,25,0.89 [0.30-2.66],0.8316032771505711
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18654,444,0.94 [0.72-1.22],0.6315740933067027
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18583,373,0.92 [0.69-1.22],0.5467097064379492
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,18816,240,1.19 [0.88-1.62],0.265970402323356
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23485,141,1.14 [0.75-1.72],0.5329504471900104
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23380,36,0.69 [0.24-1.96],0.4861602129306398
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21272,44,1.08 [0.50-2.33],0.8393283343606033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21426,198,1.03 [0.71-1.49],0.8872067684630794
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22015,787,1.02 [0.84-1.23],0.8681816374116345
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21350,122,0.77 [0.44-1.32],0.3368553323910768
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21277,49,1.13 [0.56-2.28],0.7345206720802075
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21888,660,0.99 [0.80-1.22],0.9397520018412764
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21276,48,1.54 [0.90-2.66],0.1181866307844355
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21454,226,0.74 [0.49-1.10],0.1369221745699033
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21329,101,0.70 [0.38-1.29],0.254296509633155
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21286,58,1.03 [0.52-2.01],0.9386790025316544
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21348,120,1.11 [0.70-1.76],0.6460346863112347
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21286,58,1.24 [0.67-2.30],0.4885045822044694
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21512,284,0.82 [0.57-1.16],0.2571132430717512
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21016,243,1.24 [0.92-1.67],0.1668056522792718
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20818,45,1.28 [0.65-2.54],0.4777448365704471
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20816,43,1.71 [1.04-2.83],0.0361187343529295
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20875,102,0.96 [0.56-1.65],0.8881426536409288
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20824,51,1.21 [0.63-2.32],0.572678907837276
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20826,53,0.88 [0.40-1.93],0.7562148824411229
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20814,41,0.72 [0.28-1.87],0.5004604686940028
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20958,185,0.99 [0.66-1.46],0.9422726368413036
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20817,44,1.28 [0.64-2.54],0.4873955779758991
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20816,43,1.16 [0.54-2.47],0.7076218320963106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20864,91,1.02 [0.59-1.76],0.9566947520829115
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20838,65,1.29 [0.73-2.25],0.3778145392125993
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21149,376,1.13 [0.87-1.46],0.3619679088094798
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20904,131,1.37 [0.94-1.99],0.1016404930386624
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20969,196,1.12 [0.78-1.60],0.5548844419646607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22635,92,1.08 [0.63-1.84],0.7904635148938928
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22836,293,1.10 [0.81-1.48],0.5472148459355614
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22591,48,1.31 [0.68-2.52],0.4162061567328898
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22599,56,1.17 [0.62-2.22],0.6333419064671784
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22642,99,0.82 [0.46-1.47],0.5082329859227344
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20181,3780,1.04 [0.94-1.14],0.4498212474755884
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,9665,343,1.09 [0.82-1.45],0.5471106122241604
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,22558,157,1.30 [0.91-1.85],0.1521389831228407
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22445,44,2.00 [1.29-3.08],0.0017868762991227
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22699,33,0.58 [0.18-1.84],0.358552977390836
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22694,28,1.57 [0.77-3.19],0.2146303034126592
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22705,39,1.10 [0.50-2.45],0.8078251729292166
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23518,205,0.98 [0.67-1.42],0.8994878169257381
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23585,44,0.54 [0.20-1.47],0.2275248309953703
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23455,142,1.06 [0.69-1.63],0.7973058524908843
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23399,86,1.37 [0.87-2.16],0.1721337109241728
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22518,762,0.96 [0.79-1.18],0.720815249568812
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Cystitis,21824,68,1.51 [0.94-2.44],0.0885775903415014
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,0.87 [0.41-1.85],0.7227237338205514
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21912,156,0.95 [0.62-1.48],0.8301442066236497
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21836,80,0.60 [0.29-1.24],0.1683689463941621
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22291,535,1.07 [0.85-1.33],0.5626138154873399
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9381,59,0.88 [0.41-1.86],0.7313541882023857
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9355,33,1.93 [1.11-3.37],0.0204529663912887
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,9357,35,1.62 [0.84-3.11],0.147402628851778
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9394,72,0.50 [0.22-1.11],0.0884724129250479
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9379,57,1.21 [0.65-2.27],0.5415550706512289
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9402,80,1.47 [0.92-2.35],0.1043730781746144
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13024,217,1.07 [0.77-1.50],0.6731746686923007
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12871,64,1.19 [0.67-2.11],0.5528602560347957
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,12880,73,1.40 [0.88-2.21],0.152254337447134
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12855,48,0.70 [0.30-1.67],0.4256714474843701
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12991,333,0.86 [0.63-1.17],0.3227318660467797
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,12729,71,0.60 [0.29-1.27],0.1835383558343222
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12826,168,1.00 [0.67-1.49],0.9952315954871264
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11988,2391,0.99 [0.88-1.11],0.8329889015560703
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,9847,250,1.06 [0.76-1.47],0.7269903705229459
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,9676,79,1.11 [0.63-1.95],0.7109002272689089
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9694,97,1.13 [0.69-1.86],0.6321786570498955
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9864,267,0.89 [0.63-1.26],0.5116614310183745
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9861,264,0.82 [0.58-1.17],0.2794557014136232
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10011,414,1.02 [0.78-1.32],0.8876440989709035
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9744,147,0.61 [0.36-1.04],0.0677615694822346
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9784,187,0.84 [0.55-1.28],0.4134887523530283
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,9668,71,1.42 [0.85-2.37],0.1818507304893075
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,9722,125,1.18 [0.77-1.83],0.4450458294715449
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",13152,175,1.22 [0.86-1.73],0.2749890622421981
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,13159,168,1.23 [0.86-1.75],0.2526293408626117
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,13175,95,1.09 [0.65-1.80],0.7508263630794894
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",13169,103,1.17 [0.73-1.87],0.5049811747169853
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9657,60,0.89 [0.43-1.82],0.7460946970409638
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9650,53,0.56 [0.23-1.37],0.2047701288693177
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9657,60,0.68 [0.31-1.51],0.3448162304878867
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,13089,321,1.03 [0.78-1.38],0.8167915212091337
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10583,986,1.11 [0.94-1.31],0.2058255639339996
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10272,675,1.14 [0.94-1.38],0.1891907002762077
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",13163,138,1.01 [0.65-1.56],0.971616976074418
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9898,301,1.28 [0.99-1.67],0.0607514375946
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9823,226,0.98 [0.69-1.41],0.9189693285205106
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9828,231,0.89 [0.61-1.30],0.5561735702021191
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,Female infertility,9684,87,0.73 [0.39-1.37],0.3244151295838756
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",9677,80,0.71 [0.36-1.37],0.3055005037699488
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,13169,723,1.02 [0.83-1.26],0.8181344150650607
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,13176,988,1.00 [0.83-1.20],0.9950537589007284
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,13171,383,0.78 [0.58-1.06],0.1158940407436128
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,12897,109,1.09 [0.68-1.75],0.7085371978459218
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,12943,155,0.49 [0.29-0.84],0.0095955209659888
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,12922,134,0.86 [0.52-1.41],0.5445888071902572
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",13185,139,1.10 [0.73-1.66],0.6520920695380095
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,13187,138,1.09 [0.72-1.64],0.6905020514872435
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,13184,354,1.03 [0.78-1.36],0.860342497170705
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,12933,103,0.85 [0.48-1.48],0.5554517547226527
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,13030,200,1.10 [0.78-1.56],0.5910619916146034
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,12569,123,0.66 [0.37-1.17],0.1535046602162538
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,12614,168,1.07 [0.72-1.59],0.7439742815235582
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,12648,202,1.32 [0.97-1.79],0.0759765092424296
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,12571,125,0.92 [0.56-1.52],0.7536429019234354
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,12561,115,1.14 [0.72-1.82],0.5729294538235846
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,12565,119,1.04 [0.65-1.66],0.8789181177219454
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,12379,191,0.90 [0.59-1.37],0.6326832533070811
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],12550,362,1.01 [0.75-1.35],0.9549399587860472
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,12738,550,1.14 [0.91-1.43],0.2539572237921651
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",13190,143,1.10 [0.73-1.65],0.6432683424959272
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,11990,110,1.25 [0.81-1.94],0.3112871686441504
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",12269,81,1.12 [0.64-1.94],0.6945382416687987
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,13195,277,0.76 [0.53-1.09],0.1337441347309743
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,13133,215,0.93 [0.64-1.35],0.6961073564821872
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",13184,208,0.76 [0.50-1.15],0.18965786422684
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",13174,198,0.79 [0.53-1.20],0.2712616826410006
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23619,32,1.51 [0.78-2.93],0.2225195649353496
EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,22420,446,0.88 [0.67-1.16],0.3649735700925958
